SKYE vs OPT
Comparison between Skye Bioscience Inc (SKYE, Company) and Opthea Ltd (OPT, Company).
Both SKYE and OPT are from the Healthcare sector.
SKYE vs OPT - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
SKYE
$22M
OPT
$22M
Max Drawdown
SKYE
99.96%
OPT
N/A
Sharpe Ratio
SKYE
-1.17
Winner
OPT
0.00
5Y Beta
SKYE
1.51
OPT
N/A
Industry
SKYE
Biotechnology
OPT
Biotechnology
P/E Ratio
SKYE
-0.35
Winner
OPT
-4.62
Forward P/E
SKYE
N/A
OPT
6.73
PEG Ratio
SKYE
-0.01
OPT
N/A
5Y EPS CAGR
SKYE
-21.69%
OPT
N/A
Debt to Equity
Winner
SKYE
0.00%
OPT
156.18%
P/S Ratio
Winner
SKYE
117.90
OPT
151.40
P/B Ratio
SKYE
2.40
Winner
OPT
-1.03
SKYE vs OPT - Historical Returns
Returns include dividend reinvestment.
1M
SKYE
-16.30%
Winner
OPT
+0.00%
3M
SKYE
-33.97%
Winner
OPT
+0.00%
6M
SKYE
-42.54%
Winner
OPT
+0.00%
1Y
SKYE
-83.93%
OPT
N/A
5Y(CAGR)
SKYE
-56.84%
OPT
N/A
10Y(CAGR)
SKYE
-40.95%
OPT
N/A
Max(CAGR)
SKYE
-49.35%
Winner
OPT
+0.00%
SKYE vs OPT - Annual Returns (2015 - 2026)
Returns include dividend reinvestment.
| Year | SKYE | OPT |
|---|---|---|
| 2026 | -33.92% | +0.00% |
| 2025 | -73.69% | N/A |
| 2024 | +4.04% | N/A |
| 2023 | -34.85% | N/A |
| 2022 | -70.55% | N/A |
| 2021 | +29.68% | N/A |
| 2020 | -72.41% | N/A |
| 2019 | -65.53% | N/A |
| 2018 | +116.22% | N/A |
| 2017 | -56.57% | N/A |
| 2016 | -52.81% | N/A |
| 2015 | -86.41% | N/A |
SKYE vs OPT Drawdown Comparison
The maximum drawdown for SKYE was -99.96%, occurring on Mar 27, 2026. This drawdown has not yet recovered.
The current SKYE drawdown is -99.96%.
| Rank | SKYE | OPT |
|---|---|---|
| #1 | -99.96% Apr 7, 2015 - Mar 27, 2026 | N/A |
Correlation
Correlation between SKYE and OPT is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
0.00
-101
Select Stocks to Compare
Popular: SKYE vs SPYOPT vs SPY
More Comparisons
Compare with similar stocks